4th Annual Cancer Risk and Prevention Symposium

At the conclusion of this activity, the participants should be better able to:

1. Provide evidence-based insights into key cancer risk factors—such as obesity, tobacco use, environmental exposures, and genetic predispositions—while clarifying health care roles in implementing prevention strategies like lifestyle interventions, vaccinations, and risk stratification tools.
2. Discuss new advancements in cancer screening, genetic testing, and personalized care, emphasizing effective interdisciplinary communication to optimize patient outcomes across diverse populations.
3. Identify approaches to reduce health disparities in cancer prevention and care by fostering teamwork, interdisciplinary collaboration, and equitable access through innovative strategies, policy updates, and community engagement practices.
4. Equip health care teams to identify high-risk individuals and deliver coordinated, patient-centered prevention and care.

This accredited continuing education activity is designed for primary care/internal medicine providers, advanced practice providers, genetic counselors, nurses, scientists, and other members of the cancer research teams who have an interest in familial cancer, hereditary cancer syndromes, and cancer prevention.

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Nebraska Medical Center designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses

The University of Nebraska Medical Center designates this activity for up to 6.0 ANCC contact hours. Nurses should only claim credit for the actual time spent in the activity.

Genetic Counselors

The National Society of Genetic Counselors (NSGC) has authorized UNMC  to offer up to 0.6 CEUs or 6 Category 1 contact hours for the activity 4th Annual Cancer Risk and Prevention Symposium. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.

Read the UNMC CCE Disclosure Declaration Policy 

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following have disclosed relevant financial relationships:

• Michael Haddadin, MBBS
  Advisory Board: Autolus Therapeutics
  Consultant: Aptitude Health
• Jessica Maxwell, MD, MS, FRCSC, FACS
  Consultant: Stryker
  Expert Witness: Boehringer Ingelheim International GmbH, King & Spalding LLP

• Rachael Schmidt, DNP, FNP-C, AOCNP®*
  Research: Daiichi-Sankyo Company, Limited

• Kyle Skiermont, PharmD
  Board Member: Nuvem
  Consultant: Astra Zeneca, CellTrion Inc, Leiters Health
  Speaker: BeiGene, Ltd.

 

The following faculty members have nothing to disclose:

• Amanda Bond, PA-C, MPAS*
• Kecia Christensen, APRN-NP
• Brittney Dickey, PhD, MPH
• Ashley Greenwood, MD
• Kathryn Hutchins, MD, FACG
• Molly Johnson, MSN, AOCNP-BC*
• Corrigan McBride, MD, MBA, FACS, FASMBS, DABS, DABS-FPDMBS, DABOM
• Grace Saunders, MS, LCGC
• Tiffany Seibert Joekel
• Shinobu Watanabe-Galloway, PhD

PLANNING COMMITTEE

The following has disclosed relevant financial relationships:

• Kelsey Klute, MD
  Consultant: Agenus Inc., Oncolys BioPharma Inc.
  Research: AIM ImmunoTech, Cardiff Oncology, Inc.
  Speaker: National Comprehensive Cancer Network (NCCN)

 

The following have nothing to disclose:

• Cece Abbey-Webben, MS
• Valeta Creason-Wahl, MMP
• Missy Edwards
• Julie Huglin
• Heidi Keeler, PhD, MSN/MBA, RN
• Renee Paulin, MSN, RN, CWOCN
• Brenda Ram, CMP, CHCP
• Gwen Reiser, MS, LCGC

 

*Faculty and planning committee member

The following materials (in PDF) are available for download until May 15, 2025. No part of these materials may be reproduced without prior written permission.

• Obesity, Bariatric Therapies, and Cancer Risk
  Corrigan McBride, MD, MBA, FACS, FASMBS, DABS, DABS-FPDMBS, DABOM
•  Management of High-Risk Benign Breast Lesions
  Jessica Maxwell, MD, MS, FRCSC, FACS
• Unlocking the Potential of Clonal Hematopoiesis of Indeterminate Potential (CHIP): Early Detection for Cancer and Cardiovascular
  Michael Haddadin, MBBS
• Health Disparities and Cancer Risk
  Shinobu Watanabe-Galloway, PhD
• Ovarian Cancer Screening: Are We Moving the Needle?
  Ashley Greenwood, MD
• Human Papillomavirus Vaccine (HPV) and Prevention of HPV-Associated Cancers
  Brittney Dickey, PhD, MPH
• Policy Updates for Cancer Screening
  Tiffany Seibert Joekel
• Clinician Considerations/Perspectives for High-Risk Patient Management
  Amanda Bond, PA-C, MPAS; Molly Johnson, MSN, AOCNP-BC; Rachael Schmidt, DNP, FNP, AOCNP®
• Colorectal Cancer Screening Updates
  Kathryn Hutchins, MD, FACG
• LGBTQIA2S+ Cancer Screening Considerations
  Grace Saunders, MS, LCGC
• Precision Medicine Through Population Genomics
  Kyle Skiermont, PharmD
• Tobacco Cessation: Pearls of Wisdom
  Kecia Christensen, APRN-NP